DermTech Files For Bankruptcy; To Sell Assets And Lay Off Staff

Dow Jones06-18
 

By Michael Susin

 

DermTech said on Tuesday that it filed for bankruptcy protection and that it will conduct a process to sell substantially all of its assets.

The dermatology company said it has filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware and fired 15 employees to reduce costs, representing 20% of the workforce.

The group added it will potentially lay off more staff in the future.

"Through the bankruptcy process, the company intends to safeguard the interest of stakeholders and maximize the value of its assets," it said.

The group expects to continue its laboratory operations and processing orders for the DermTech Melanoma Test while simultaneously conducting the sale of its assets.

 

Write to Michael Susin at michael.susin@wsj.com

 

(END) Dow Jones Newswires

June 18, 2024 08:28 ET (12:28 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment